Most products fail not because the science is wrong — but because the path to market is fragmented. I close that gap for three specific types of business — and their referral networks.
Your patients trust your judgment completely. They spend RM150–RM400 monthly on supplements and skincare — just not yours. Every week you send them home without a product that continues their treatment. That gap is the opportunity I work in.
I build the science-backed product system your existing patients will buy — NPRA-registered, clinically positioned, generating meaningful product revenue within 6 months.
You may have tried a generic distributor product before — it sat on the shelf. Your patients did not buy it because it felt like retail, not medicine. You need a product built around your clinical context, not a logo on someone else's formula.
You have been asked "where can I buy this?" hundreds of times. Every factory version tastes wrong, shelf life is too short for retail, and nobody can explain all three problems at once — until now.
I re-engineer the process that creates your shelf life problem at its root — not by adding preservatives, but by solving the stability failure at manufacturing level, while preserving the taste profile that made your product worth scaling.
Shelf life is not a food science problem. It is a revenue ceiling problem. We remove the ceiling.
Now six competitors have the same formulation at half your price. Your repeat purchase rate is falling. The root cause is not your marketing — your product has no moat.
I design a reformulation strategy that creates genuine intellectual property — evidence-backed, legally protected, and positioned to command a price premium that copycats cannot match without access to the same science.
A product built on real science, positioned correctly, and launched with evidence behind it, is the most powerful business moat that exists.
Every business I work with is stuck in Lane 1 and trying to find Lane 2. This is what that transition looks like — and why it is the most important strategic move any service business can make.
Time-bound revenue tied to people and operational hours
Distribution-driven revenue that scales independently
"Products do not replace service — they scale it. Build Lane 2 without breaking Lane 1. That is the only growth move that removes the ceiling without adding the headache."
— Dr. Wee Ting Lai
If you know someone in one of these situations — make the introduction. Every referral I receive, I treat as a reflection of the person who made it.
Established patient base with strong trust but zero product revenue. Has tried a generic distributor product and it did not work.
Food, skincare, supplements — any service business with manpower-bound revenue looking to build a product income stream.
Companies needing product development capability without a full-time R&D team. Projects from 3 months to ongoing retainer.
Malaysian brands entering overseas markets, or overseas brands entering Malaysia — including Halal-ready pathways for ASEAN and Middle East.
Online wellness brands whose factory-formula products are being undercut. Need a real product moat — not just better marketing.
China, Singapore, Taiwan brands who have been told Malaysia is the ASEAN gateway — and discovered "the distributor will handle everything" is not a strategy.